These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10698266)

  • 1. Molecular modeling of the oxytocin receptor/bioligand interactions.
    Politowska E; Czaplewski C; Ciarkowski J
    Acta Biochim Pol; 1999; 46(3):581-90. PubMed ID: 10698266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics simulation of human neurohypophyseal hormone receptors complexed with oxytocin-modeling of an activated state.
    Slusarz MJ; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):171-9. PubMed ID: 16114099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking ligands to vasopressin and oxytocin receptors via genetic algorithm.
    Politowska E; Drabik P; Kazmierkiewicz R; Ciarkowsk J
    J Recept Signal Transduct Res; 2002; 22(1-4):393-409. PubMed ID: 12503629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system.
    Slusarz MJ; Slusarz R; Ciarkowski J
    Biopolymers; 2006 Apr; 81(5):321-38. PubMed ID: 16333859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin receptors: ligand binding, signalling and cholesterol dependence.
    Gimpl G; Reitz J; Brauer S; Trossen C
    Prog Brain Res; 2008; 170():193-204. PubMed ID: 18655883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modelling of the vasopressin V2 receptor/antagonist interactions.
    Czaplewski C; Kaźmierkiewicz R; Ciarkowski J
    Acta Biochim Pol; 1998; 45(1):19-26. PubMed ID: 9701492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin.
    Gimpl G; Postina R; Fahrenholz F; Reinheimer T
    Eur J Pharmacol; 2005 Mar; 510(1-2):9-16. PubMed ID: 15740719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking-based study of vasopressin analogues modified at positions 2 and 3 with N-methylphenylalanine: influence on receptor-bound conformations and interactions with vasopressin and oxytocin receptors.
    Slusarz MJ; Sikorska E; Slusarz R; Ciarkowski J
    J Med Chem; 2006 Apr; 49(8):2463-9. PubMed ID: 16610789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of interactions of the non-peptide antagonist YM087 with the human vasopressin V1a, V2 receptors and with oxytocin receptors.
    Giełdoń A; Kaźmierkiewicz R; Slusarz R; Ciarkowski J
    J Comput Aided Mol Des; 2001 Dec; 15(12):1085-104. PubMed ID: 12160092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-specific requirement for a glutamate in transmembrane helix 1 of the oxytocin receptor.
    Wootten DL; Simms J; Massoura AJ; Trim JE; Wheatley M
    Mol Cell Endocrinol; 2011 Feb; 333(1):20-7. PubMed ID: 21130837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.
    Postina R; Kojro E; Fahrenholz F
    Adv Exp Med Biol; 1998; 449():371-85. PubMed ID: 10026828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A plasmin-derived hexapeptide from the carboxyl end of osteocalcin counteracts oxytocin-mediated growth inhibition [corrected] of osteosarcoma cells.
    Novak JF; Judkins MB; Chernin MI; Cassoni P; Bussolati G; Nitche JA; Nishimoto SK
    Cancer Res; 2000 Jul; 60(13):3470-6. PubMed ID: 10910058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residues in the hydrophilic face of putative helix 8 of oxytocin receptor are important for receptor function.
    Zhong M; Navratil AM; Clay C; Sanborn BM
    Biochemistry; 2004 Mar; 43(12):3490-8. PubMed ID: 15035619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional architecture of vasopressin/oxytocin receptors.
    Hibert M; Hoflack J; Trumpp-Kallmeyer S; Mouillac B; Chini B; Mahé E; Cotte N; Jard S; Manning M; Barberis C
    J Recept Signal Transduct Res; 1999; 19(1-4):589-96. PubMed ID: 10071787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol-induced conformational changes in the oxytocin receptor.
    Muth S; Fries A; Gimpl G
    Biochem J; 2011 Aug; 437(3):541-53. PubMed ID: 21561435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modelling study of the role of cholesterol in the stimulation of the oxytocin receptor.
    Politowska E; Kaźmierkiewicz R; Wiegand V; Fahrenholz F; Ciarkowski J
    Acta Biochim Pol; 2001; 48(1):83-93. PubMed ID: 11440186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of neurophysin/bioligand interactions from molecular modeling.
    Kaźmierkiewicz R; Czaplewski C; Ciarkowski J
    Acta Biochim Pol; 1997; 44(3):453-66. PubMed ID: 9511957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin-receptor binding: why divalent metals are essential.
    Liu D; Seuthe AB; Ehrler OT; Zhang X; Wyttenbach T; Hsu JF; Bowers MT
    J Am Chem Soc; 2005 Feb; 127(7):2024-5. PubMed ID: 15713062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.